PHIBRO ANIMAL HEALTH CORP (PAHC) Form 10-K — Aug 26, 2026
Phibro Animal Health's fiscal 2026 annual report shows net sales of $1,518 million, up 17% from $1,296 million in fiscal 2025, with Adjusted EBITDA up 39% to $255 million. Growth was broad-based, with the Animal Health segment up 21% to $1,162 million. The October 2024 acquisition of Zoetis's medicated feed additive portfolio for approximately $297.5 million was the primary growth driver, contributing $358.2 million of fiscal 2026 net sales versus $208.2 million in fiscal 2025. The acquired portfolio spans more than 37 product lines sold in roughly 80 countries.
Key figures
- Revenue
- $1,518 million
- Revenue Yoy
- 17%
- Shares Outstanding
- 21,105,569 Class A and 19,496,034 Class B as of August 21, 2026
- Product Lines
- approximately 790 product lines in approximately 90 countries to approximately 4,800 customers
- Adjusted Ebitda
- $255 million (FY2026) vs $184 million (FY2025), +39%
- Brazil Exposure
- 12% of net sales and 12% of consolidated assets (FY2026)
- Israel Exposure
- 16% of net sales and 18% of consolidated assets (FY2026)
- Mfa And Other Sales
- $811 million (FY2026) vs $646 million (FY2025)
- Mecadox Carbadox Sales
- approximately $21 million (FY2026)
- Mineral Nutrition Sales
- $282 million, +11% YoY
- Zoetis Acquisition Price
- $297.5 million ($286.5 million as adjusted, net of cash acquired), completed October 31, 2024
- Non Affiliate Market Value
- $763,701,688 as of December 31, 2025
- Animal Health Segment Sales
- $1,162 million, +21% YoY
- Performance Products Sales
- $74 million, -8% YoY
- Acquired Portfolio Contribution
- $358.2 million (FY2026) and $208.2 million (FY2025) of net sales
- Medicated Products Percent Of Net Sales
- 54% (FY2026) and 50% (FY2025)
Price after filing
Close on the filing date to close N calendar days later (from $35.93). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.